Cargando…
Severe multisystem inflammatory syndrome in a vaccinated adult with COVID-19
The ability of SARS-CoV-2 to trigger hyperinflammatory response in children and adults is increasingly recognised. However, the detailed features that distinguish severe COVID-19-associated hyperinflammation from multisystem inflammatory syndrome in adults (MIS-A) is not yet known. We describe a you...
Autores principales: | Selvaraj, Vijairam, Finn, Arkadiy, Santos, Michael, Dapaah-Afriyie, Kwame |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045045/ https://www.ncbi.nlm.nih.gov/pubmed/35473700 http://dx.doi.org/10.1136/bcr-2022-249425 |
Ejemplares similares
-
The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19
por: Finn, Arkadiy, et al.
Publicado: (2022) -
Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
por: Selvaraj, Vijairam, et al.
Publicado: (2021) -
A Tale of Two Ps: Panniculitis Secondary to Acute Pancreatitis
por: Selvaraj, Vijairam, et al.
Publicado: (2021)